Through you, Madam Chair, thank you.
The task force, as you know, provides recommendations for a broad array of topics, with breast cancer being one of them. In guideline development, it is recommended that those to whom the guideline is directed—for us, it's primary care—be the constituents of that panel. The experts have a perspective that differs from primary care. Theirs is completely valid in their realm of practice, and our perspectives are equally valid in our practice.